India, Oct. 5 -- A trial fibrillation (AFib) is currently the most prevalent type of disturbance of heart rhythm, affecting millions of people around the world. During AFib, the upper chambers (atria) of the heart beat irregularly and out of time with the lower chambers (ventricles). Atrial fibrillation significantly increases stroke risk because the rapid heart rhythm leads to blood pooling and clotting in the heart, particularly in the left atrial appendage, a small pouch in the heart. These clots can dislodge, travel to the brain, and block blood flow, causing a stroke. AFib is a major cause of ischaemic strokes, and strokes related to AFib are often more severe. However, stroke risk can be reduced with treatments like blood-thinning (anticoagulant) medications and other interventional procedures. Before diagnosis and treatment can be implemented, a combination of patient history, physical examination, and a number of diagnostic tests needs to take place. These tests may involve electrocardiograms (ECGs), Holter monitoring, echocardiograms, and blood tests to rule out possible underlying causes such as thyroid disease, electrolyte disturbance, etc. The traditional pathway of treatment is medication, including anti-arrhythmia medications, beta-blockers, and anticoagulants. Radio frequency ablation, abbreviated as RFA, is one of those methods that has the potential to be extremely effective and may well be the best treatment strategy for a specific subset of patients with AFib. RFA is a minimally invasive procedure that affords patients long-term resolution of AFib symptoms while minimising the likelihood of progression to more serious cardiac rhythm disorders.htc...